Pfizer signs $1.24 billion deal with New Haven biotech for marketing of migraine drug
Under the terms of the deal, Pfizer will market Nurtec ODT around the world except for the United States. |!| New Haven
Under the terms of the deal, Pfizer will market Nurtec ODT around the world except for the United States. |!| New Haven